3,956
Views
53
CrossRef citations to date
0
Altmetric
Brief Report

CD20-selective inhibition of CD47-SIRPα “don't eat me” signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumab

, , , , , , , , , , & show all
Article: e1386361 | Received 02 Aug 2017, Accepted 24 Sep 2017, Published online: 31 Oct 2017